Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Research And Trials

Some aggressive ovarian cancers start in the fallopian tubes, not the ovaries

The most aggressive type of ovarian cancer develops from cells that come from the fallopian tubes rather than the ovaries, according to a small study.

Internal radiotherapy: tackling cancer from within

Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.

Researchers "drug the undruggable" through unique collaboration

A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia

Personalised treatments for rare cancers tested in study

A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers.

Our milestones: A radical change that improved breast cancer surgery

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

Taking part in clinical trials – Tommy’s story

In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial.

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

Two treatments for advanced prostate cancer bring equal benefits

Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

Pages